Merck & Co Inc (NYSE:MRK)
$ 130.38 2.81 (2.2%) Market Cap: 330.23 Bil Enterprise Value: 351.71 Bil PE Ratio: 144.87 PB Ratio: 8.18 GF Score: 85/100

Q2 2019 Merck & Co Inc Earnings Call Transcript

Jul 30, 2019 / 12:00PM GMT
Release Date Price: $79.4 (+0.95%)
Operator

Good morning. My name is Darla, and I will be your conference operator today. At this time, I would like to welcome everyone to the Merck & Co. Q2 sales and earnings conference call. (Operator Instructions)

I would now like to turn the call over to Teri Loxam, SVP, Investor Relations and Global Communications. Please go ahead.

Teri Loxam
Merck & Co., Inc. - Senior VP of IR & Global Communications

Thank you, Darla, and good morning. Welcome to Merck's second quarter 2019 conference call. Today, I'm joined by Ken Frazier, our Chairman and Chief Executive Officer; Rob Davis, our Chief Financial Officer; and Dr. Roger Perlmutter, President of Merck Research Labs, who will each have prepared remarks. In addition, I'm also joined by Mike Nally, our Chief Marketing Officer; and Frank Clyburn, our Chief Commercial Officer, who will be available for the Q&A portion of the call.

Before I turn the call over to Ken, I'd like to point out a few items. You will see that we have items in our GAAP results such as acquisition-related charges,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot